Chief Medical Officer
Antonio joined Enthera as CMO in 2021.
He has over 22 years of experience in devising clinical development and registration strategies for small molecules and biologics across various therapeutic areas, such as gastroenterology, rheumatology, nephrology, transplantation and rare diseases.
Prior to Enthera, Antonio was Translational Medicine Leader at Galapagos. He previously held senior management positions at global life sciences companies, including Global Program Clinical Head at Novartis; Medical Director, Italy at Shire; Manager of Medical Affairs at Genzyme; and Senior Product Manager at Wyeth.
Antonio is a Board-certified surgeon and author of several publications in the areas of transplantation, immunology and rheumatology in major peer-reviewed journals.